EC Number   |
Application |
Reference |
|---|
   3.4.11.21 | drug development |
enzyme TgAAP deletion results in inhibition, but not abolition, of invasion and growth of Toxoplasma gondii in cell culture, thus indicating that the enzyme may be a promising adjunct target for anti-toxoplasma drug development |
-, 755445 |
| 3.4.11.21 | drug development |
the M18 aspartyl aminopeptidase is a valid target to develop antimalarial drugs |
753110 |
| 3.4.11.21 | drug development |
the M18 aspartyl aminopeptidase is a valid target to develop antimalarial drugs against the drug resistant strains of malaria parasite |
752973 |
| 3.4.11.21 | medicine |
enzyme is not present in the urine of healthy rats, however, it is readily detected in the urine in rat models of mild and heavy proteinuria. Urinary levels correlate with the severity of proteinuria |
731109 |
| 3.4.11.21 | synthesis |
dipeptide sweeteners aspartame and alitame |
137171 |
